Combating giardiasis by investigating new potent compound series as leads for improved treatment options [ 2018 - 2020 ]

Research Grant

Researchers: Dr Tina Skinner-Adams (Principal investigator) ,  A/Pr Aaron Jex ,  Dr Jack Ryan

Brief description Giardia parasites infect ~1 billion people globally and are responsible for significant morbidity and disadvantage. There is no licensed vaccine and current treatment options are inadequate, resulting in poor compliance, treatment failures, rapid re-infection and drug resistance. New therapies are needed to combat this parasite and improve the health of millions world-wide. We will address this issue by investigating new drug candidates for the treatment of Giardia infections.

Funding Amount $AUD 786,892.20

Funding Scheme Project Grants

Notes Standard Project Grant